ArticleTheranostics2026

Clinically accessible drug-based nano-assemblies with self-targeting ability for NIR-II fluorescence imaging-guided surgery in triple-negative breast cancer.

Ruiqin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.